×

Was Ranbaxy stake sale right for Daiichi Sankyo?

8:33 PM ET Mon, 7 April 2014

Emilia Falcetti, Analyst, Japan Healthcare Equity Research at Cantor Fitzgerald, says Daiichi Sankyo's decision to sell its controlling stake in Ranbaxy will have a negative impact on its earnings.